lilly glp-1 drug Diabetes Patients Also Struggle to Access Agonists Ozempic and Other Drugs to

Although these mechanisms have been exploited to facilitate weight loss, these medications have also been indicated for patients with cardiovascular or renal diseases, all of which have caused a recent drastic rise in prescribing GLP-1 RAs

We comprehensively mapped the benefits and risks of GLP-1 receptor agonists (GLP-1) (Ozempic, Wegovy, Mounjaro, Zepbound)

GLP-1 receptor agonists are medications used to manage obesity and type 2 diabetes

Methods A systematic review was conducted following PRISMA 2020 guidelines (PROSPERO: CRD420261305875)

The fascinating history of the GLP-1 drugs- Ozempic, Wegovy, and Mounjaro.

While several multisociety statements have been published recently, the recommendations vary significantly in terms of medication ...